Andreas Kreiss

Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib

R. Lehmann, Marek Brzosko, Petr Kopsa et al. · Current Medical Research and Opinion · 2005 · 73 citations

Medicine, Orthopaedic Surgery, Pharmacotherapy +15

Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout

R. Willburger, Eduardo Mysler, J. Derbot et al. · Lara D. Veeken · 2007 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom

Peter Layer, Jutta Keller, Helena Loeffler et al. · Therapeutics and Clinical Risk Management · 2007 · 26 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15